The Hippo pathway in disease and therapy: cancer and beyond-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Hippo pathway in disease and therapy: cancer and beyond

Published:2014-07-10 Issue:1 Volume:3 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical and Translational Medicine

Author:

Gomez Marta¹,Gomez Valenti¹,Hergovich Alexander¹

Affiliation:

1. Tumour Suppressor Signalling Networks laboratoryUCL Cancer InstituteUniversity College London72 Huntley StreetWC1E 6BTLondonUK

Funder

Biotechnology and Biological Sciences Research Council

Wellcome Trust

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1186/2001-1326-3-22

Reference126 articles.

1. The Hippo pathway: regulators and regulations

2. Hippo signaling inDrosophila: Recent advances and insights

3. The Hippo pathway and human cancer

4. The YAP and TAZ transcription co-activators: Key downstream effectors of the mammalian Hippo pathway

5. The Ste20 group kinases as regulators of MAP kinase cascades

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the Hippo Pathway in Cutaneous Melanoma;Cells;2024-06-19

2. Neurofibromin 2 modulates Mammalian Ste2-like kinases1/2 and large tumor suppressor gene1 expression in A549 lung cancer cell line;American Journal of Translational Research;2024

3. Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation;International Journal of Molecular Sciences;2023-03-22

4. Clinicopathological Significance of DUB3 Expression in Non-small Cell Lung Cancer and Relationship Between DUB3 Expression and LATS1 Expression;In Vivo;2023

5. Identification of a Yorkie homolog from Litopenaeus vannamei as a negative regulator in anti-WSSV immune response;Fish & Shellfish Immunology;2022-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3